ASLAN Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ASLN and buy or sell other stocks, ETFs, and their options commission-free!About ASLN
Aslan Pharmaceuticals Ltd. is a clinical-stage immunology biopharmaceutical company, which develops novel therapeutics. It focuses on atopic dermatitis, other immunology indications and autoimmune disease.
CEOCarl Aslan Jason Morton Firth, PhD, EMBA
CEOCarl Aslan Jason Morton Firth, PhD, EMBA
Employees—
Employees—
HeadquartersSingapore, Central Singapore
HeadquartersSingapore, Central Singapore
Founded2010
Founded2010
Employees—
Employees—
ASLN Key Statistics
Market cap1.70M
Market cap1.70M
Price-Earnings ratio-0.04
Price-Earnings ratio-0.04
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.32
52 Week high$4.32
52 Week low$0.475
52 Week low$0.475
Stock Snapshot
The current ASLAN Pharmaceuticals(ASLN) stock price is $0.55, with a market capitalization of 1.7M. The stock trades at a price-to-earnings (P/E) ratio of -0.04.
During the trading day, ASLAN Pharmaceuticals(ASLN) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0.
The stock's 52-week range extends from a low of $0.48 to a high of $4.32.
The stock's 52-week range extends from a low of $0.48 to a high of $4.32.